Use of Win Statistics to Analyze Outcomes in the DAPA-HF and DELIVER Trials.

NEJM evidence（2023）

引用 0|浏览5

暂无评分

摘要

Win Statistics in HF TrialsIn this study, we applied win statistics to the DAPA-HF and DELIVER trials, exploring the effect of dapagliflozin on a composite outcome incorporating patient-reported outcomes as well as total heart failure events and cardiovascular deaths.

查看译文

关键词

win statistics,trials,outcomes

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要